IMURAN
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
54766-590 -
Package NDC
54766-590-10 -
Application number
NDA016324 -
SPL ID
431426e8-80d4-a4e2-e063-6394a90af918 -
SPL set ID
606101a0-6244-7eff-e053-2a91aa0acadd -
UNII
MRK240IY2L -
RxCUI
105611 -
RxCUI
197388
What the source publishes
- Labeler
- Sebela Pharmaceuticals Inc.
- Active ingredients
- azathioprine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "IMURAN",
"splId": "431426e8-80d4-a4e2-e063-6394a90af918",
"labels": [
{
"setId": "606101a0-6244-7eff-e053-2a91aa0acadd",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=606101a0-6244-7eff-e053-2a91aa0acadd",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=606101a0-6244-7eff-e053-2a91aa0acadd"
}
],
"routes": [
"ORAL"
],
"labeler": "Sebela Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (54766-590-10)",
"package_ndc": "54766-590-10",
"identifierStatus": "well-formed",
"marketing_end_date": "20280430",
"marketing_start_date": "20171201"
}
],
"productId": "54766-590_431426e8-80d4-a4e2-e063-6394a90af918",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "54766-590",
"deaSchedule": null,
"genericName": "azathioprine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": "20280430",
"activeIngredients": [
{
"name": "AZATHIOPRINE",
"strength": "50 mg/1"
}
],
"applicationNumber": "NDA016324",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171201",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000233",
"M0015066",
"N0000175712",
"M0018169"
],
"upc": [
"0354766590108"
],
"unii": [
"MRK240IY2L"
],
"rxcui": [
"105611",
"197388"
],
"spl_set_id": [
"606101a0-6244-7eff-e053-2a91aa0acadd"
],
"pharm_class_cs": [
"Nucleosides [CS]",
"Purines [CS]"
],
"pharm_class_epc": [
"Purine Antimetabolite [EPC]"
],
"pharm_class_moa": [
"Nucleic Acid Synthesis Inhibitors [MoA]"
],
"manufacturer_name": [
"Sebela Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:54766-590_431426e8-80d4-a4e2-e063-6394a90af918"